Haemonetics Corp. (HAE)

Haemonetics (HAE) Stock Price & Analysis


HAE Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$58.23 - $91.39
Previous Close$86.89
Average Volume (3M)300.18K
Market Cap
Enterprise Value$4.85B
Total Cash (Recent Filing)$284.47M
Total Debt (Recent Filing)$765.89M
Price to Earnings (P/E)38.7
Aug 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.25
Shares Outstanding50,540,770
10 Day Avg. Volume258,456
30 Day Avg. Volume300,176
Standard Deviation0.12
Financial Highlights & Ratios
Price to Book (P/B)58.61
Price to Sales (P/S)3.76
Price to Cash Flow (P/CF)13.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.61
Enterprise Value/Gross Profit7.89
Enterprise Value/Ebitda27.93
Price Target Upside20.11% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Haemonetics Corp.’s price range in the past 12 months?
Haemonetics Corp. lowest stock price was $58.23 and its highest was $91.39 in the past 12 months.
    What is Haemonetics Corp.’s market cap?
    Currently, no data Available
    When is Haemonetics Corp.’s upcoming earnings report date?
    Haemonetics Corp.’s upcoming earnings report date is Aug 08, 2023 which is in 61 days.
      How were Haemonetics Corp.’s earnings last quarter?
      Haemonetics Corp. released its earnings results on May 11, 2023. The company reported $0.77 earnings per share for the quarter, beating the consensus estimate of $0.704 by $0.066.
        Is Haemonetics Corp. overvalued?
        According to Wall Street analysts Haemonetics Corp.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Haemonetics Corp. pay dividends?
          Haemonetics Corp. does not currently pay dividends.
          What is Haemonetics Corp.’s EPS estimate?
          Haemonetics Corp.’s EPS estimate is $0.73.
            How many shares outstanding does Haemonetics Corp. have?
            Haemonetics Corp. has 50,540,770 shares outstanding.
              What happened to Haemonetics Corp.’s price movement after its last earnings report?
              Haemonetics Corp. reported an EPS of $0.77 in its last earnings report, beating expectations of $0.704. Following the earnings report the stock price went up 3.297%.
                Which hedge fund is a major shareholder of Haemonetics Corp.?
                Among the largest hedge funds holding Haemonetics Corp.’s share is Fisher Asset Management LLC. It holds Haemonetics Corp.’s shares valued at 86M.


                  Haemonetics Stock Smart Score

                  The Haemonetics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Haemonetics Corp.

                  Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following geographical segments: Japan, EMEA (Europe, the Middle East, and Africa), North America Plasma, and All Other. Its products include surgical and diagnostic devices, blood and plasma center devices, blood center software, hospital software, and plasma center software. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Braintree, MA.


                  Top 5 ETFs holding HAE

                  Market Value
                  Smart Score
                  Vanguard Health Care ETF
                  iShares Core S&P Total U.S. Stock Market ETF
                  iShares Core S&P U.S. Growth ETF
                  Schwab U.S. Broad Market ETF
                  Fidelity MSCI Health Care Index ETF
                  Up to five ETFs with an Outperform Smart Score that hold HAE. The ETFs are listed according to market value of HAE within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Alphatec Holdings
                  Helius Medical Technologies

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis